FDA Expedited Program Designations to Support Rare Disease Drug Development

FDA Expedited Program Designations to Support Rare Disease Drug Development
By: Christine Clarke PhD, Senior Medical Writer
One in 10 Americans is affected by rare diseases—more than half of which are children—and approximately 95% of the more than 7,000 rare diseases have no available treatments.

Read the source article at Data CRO
2021-12-01 12:14:08